Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial
Download the PDF here.
This post appeared first on investingnews.com
You May Also Like
Stock News
Tech stocks were hit with selling pressure to start the year, but many are still in long-term trends and some are nearing support-reversal zones....
World News
PORTSMOUTH, N.H. — Former president Donald Trump is aiming for a crushing victory in Iowa on Jan. 15. But it is the New Hampshire...
World News
DES MOINES — Ron DeSantis and Nikki Haley held back-to-back CNN town halls in Iowa on Thursday as they fight to emerge as the...
Investing News
Australian Vanadium Limited (ASX: AVL, “the Company” or “AVL”) is pleased to announce that it has successfully commissioned its vanadium electrolyte manufacturing facility (Facility)...